In Situ-Targeting of Dendritic Cells with Donor-Derived Apoptotic Cells Restrains Indirect Allorecognition and Ameliorates Allograft Vasculopathy

Zhiliang Wang, William J. Shufesky, Angela Montecalvo et al. · 2009

Read In Situ-Targeting of Dendritic Cells with Donor-Derived Apoptotic Cells Restrains Indirect Allorecognition and Ameliorates Allograft Vasculopathy by Zhiliang Wang, William J. Shufesky, Angela Montecalvo et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004940.txt.

Description

Transplanted organs often fail years after surgery. Their blood vessels slowly narrow and clog. The process is called chronic allograft vasculopathy. Standard immune-suppressing drugs fail to prevent it. Zhiliang Wang and colleagues tested a different strategy in PLOS ONE in 2009. They targeted dendritic cells inside the recipient's body. The treatment used dying cells taken from the donor.

Dendritic cells take up these donor cells. They then present donor material in a calming way. That restrains indirect allorecognition, the slow immune route driving vessel damage. In tests, the approach eased the vessel disease. It suggests tolerance can be taught, not forced with lifelong drugs.

Catalog record

CREATORZhiliang Wang, William J. Shufesky, Angela Montecalvo et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004940

Browse the full library · About the Tower of Babel